These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

242 related articles for article (PubMed ID: 10402443)

  • 1. Prognostic value of myocardial ischemia and viability in patients with chronic left ventricular ischemic dysfunction.
    Pasquet A; Robert A; D'Hondt AM; Dion R; Melin JA; Vanoverschelde JL
    Circulation; 1999 Jul; 100(2):141-8. PubMed ID: 10402443
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Positron emission tomography for the assessment of myocardial viability: an evidence-based analysis.
    Medical Advisory Secretariat
    Ont Health Technol Assess Ser; 2005; 5(16):1-167. PubMed ID: 23074467
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prognostic value of dobutamine echocardiography in patients with left ventricular dysfunction.
    Williams MJ; Odabashian J; Lauer MS; Thomas JD; Marwick TH
    J Am Coll Cardiol; 1996 Jan; 27(1):132-9. PubMed ID: 8522686
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Head-to-head comparison of exercise-redistribution-reinjection thallium single-photon emission computed tomography and low dose dobutamine echocardiography for prediction of reversibility of chronic left ventricular ischemic dysfunction.
    Vanoverschelde JL; D'Hondt AM; Marwick T; Gerber BL; De Kock M; Dion R; Wijns W; Melin JA
    J Am Coll Cardiol; 1996 Aug; 28(2):432-42. PubMed ID: 8800122
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Thallium-201 scintigraphy and dobutamine echocardiography in the assessment of myocardial viability].
    Peral V; Vilacosta I; de la Peña A; San Román JA; Fernández C; Hernández M; Batlle E; Carreras JL; Bethencourt A
    Rev Clin Esp; 2001 Jan; 201(1):5-15. PubMed ID: 11293986
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prognostic value of myocardial viability recognized by low-dose dobutamine echocardiography in chronic ischemic left ventricular dysfunction.
    Sicari R; Picano E; Cortigiani L; Borges AC; Varga A; Palagi C; Bigi R; Rossini R; Pasanisi E;
    Am J Cardiol; 2003 Dec; 92(11):1263-6. PubMed ID: 14636900
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Preoperative selection of patients with severely impaired left ventricular function for coronary revascularization. Role of low-dose dobutamine echocardiography and exercise-redistribution-reinjection thallium SPECT.
    Vanoverschelde JL; Gerber BL; D'Hondt AM; De Kock M; Dion R; Wijns W; Melin JA
    Circulation; 1995 Nov; 92(9 Suppl):II37-44. PubMed ID: 7586440
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Why do patients with ischemic cardiomyopathy and a substantial amount of viable myocardium not always recover in function after revascularization?
    Schinkel AF; Poldermans D; Rizzello V; Vanoverschelde JL; Elhendy A; Boersma E; Roelandt JR; Bax JJ
    J Thorac Cardiovasc Surg; 2004 Feb; 127(2):385-90. PubMed ID: 14762345
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Usefulness of myocardial viability or ischemia in predicting long-term survival for patients with severe left ventricular dysfunction undergoing revascularization.
    Liao L; Cabell CH; Jollis JG; Velazquez EJ; Smith WT; Anstrom KJ; Pappas PA; Ryan T; Kisslo JA; Landolfo CK
    Am J Cardiol; 2004 May; 93(10):1275-9. PubMed ID: 15135703
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical importance of viability assessment in chronic ischemic heart failure.
    Calhoun WB; Mills RM; Drane WE
    Clin Cardiol; 1996 May; 19(5):367-9. PubMed ID: 8723594
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Myocardial viability in ischemic heart disease: new directions and perspectives.
    Previtali M
    Ital Heart J; 2001 Feb; 2(2):93-9. PubMed ID: 11256549
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Myocardial viability on echocardiography predicts long-term survival after revascularization in patients with ischemic congestive heart failure.
    Senior R; Kaul S; Lahiri A
    J Am Coll Cardiol; 1999 Jun; 33(7):1848-54. PubMed ID: 10362184
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Determining myocardial viability in chronic ischemic left ventricular dysfunction: a prospective comparison of rest-redistribution thallium 201 single-photon emission computed tomography, nitroglycerin-dobutamine echocardiography, and intracoronary myocardial contrast echocardiography.
    Ling LH; Christian TF; Mulvagh SL; Klarich KW; Hauser MF; Nishimura RA; Pellikka PA
    Am Heart J; 2006 Apr; 151(4):882-9. PubMed ID: 16569554
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of moderate exercise training on thallium uptake and contractile response to low-dose dobutamine of dysfunctional myocardium in patients with ischemic cardiomyopathy.
    Belardinelli R; Georgiou D; Ginzton L; Cianci G; Purcaro A
    Circulation; 1998 Feb; 97(6):553-61. PubMed ID: 9494025
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Detection of myocardial viability in the prediction of improvement in left ventricular function after successful coronary revascularization by using the dobutamine stress echocardiography and quantitative SPECT rest-redistribution-reinjection 201TI imaging after dipyridamole infusion.
    Kostopoulos KG; Kranidis AI; Bouki KP; Antonellis JP; Kappos KG; Rodogianni FE; Zamanis NJ; Tavernarakis AG; Lolas CT; Anthopoulos LP
    Angiology; 1996 Nov; 47(11):1039-46. PubMed ID: 8921752
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of dobutamine echocardiography, dobutamine sestamibi, and rest-redistribution thallium-201 single-photon emission computed tomography for determining contractile reserve and myocardial ischemia in ischemic cardiomyopathy.
    Amanullah AM; Chaudhry FA; Heo J; Galatro K; Dourdoufis P; Brozena S; Narula J; Iskandrian AE
    Am J Cardiol; 1999 Sep; 84(6):626-31. PubMed ID: 10498129
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Relation between thallium uptake and contractile response to dobutamine. Implications regarding myocardial viability in patients with chronic coronary artery disease and left ventricular dysfunction.
    Panza JA; Dilsizian V; Laurienzo JM; Curiel RV; Katsiyiannis PT
    Circulation; 1995 Feb; 91(4):990-8. PubMed ID: 7850986
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Low dose wall motion score predicts the short and long-term benefit of surgical revascularization in patients with ischemic left ventricular dysfunction.
    Abdul Ghaffar Y; Maskoun W; Mustafa NG; Feigenbaum H; Sawada SG
    Int J Cardiovasc Imaging; 2019 Sep; 35(9):1651-1659. PubMed ID: 31053980
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Assessment of myocardial viability with dobutamine stress echocardiography in patients with ischemic left ventricular dysfunction.
    Yao SS; Chaudhry FA
    Echocardiography; 2005 Jan; 22(1):71-83. PubMed ID: 15660693
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prognosis of patients with left ventricular dysfunction, with and without viable myocardium after myocardial infarction. Relative efficacy of medical therapy and revascularization.
    Lee KS; Marwick TH; Cook SA; Go RT; Fix JS; James KB; Sapp SK; MacIntyre WJ; Thomas JD
    Circulation; 1994 Dec; 90(6):2687-94. PubMed ID: 7994809
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.